Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
11.22 USD | -1.62% | +1.17% | +0.27% |
Apr. 05 | Arbutus Biopharma Obtains Favorable Court Order in Moderna Patent Lawsuit | MT |
Apr. 04 | Moderna Suffers Setback in Lawsuit by Arbutus | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.27% | 9.19B | |
+32.32% | 694B | |
+29.39% | 593B | |
-1.48% | 371B | |
+20.14% | 331B | |
+7.20% | 290B | |
+14.25% | 239B | |
-3.03% | 209B | |
+10.02% | 209B | |
+8.46% | 169B |
- Stock Market
- Equities
- ROIV Stock
- News Roivant Sciences Ltd.
- Roivant Sciences Insider Sold Shares Worth $1,058,694, According to a Recent SEC Filing